Cargando…

Uncovering the mechanism of action of aspirin in HCC chemoprevention

Detalles Bibliográficos
Autores principales:	Roehlen, Natascha, Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712274/ https://www.ncbi.nlm.nih.gov/pubmed/31399384 http://dx.doi.org/10.1016/j.ebiom.2019.07.047

Ejemplares similares

The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer
por: THAKKAR, ARVIND, et al.
Publicado: (2013)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
por: Roehlen, Natascha, et al.
Publicado: (2020)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

Tight Junction Protein Signaling and Cancer Biology
por: Nehme, Zeina, et al.
Publicado: (2023)

Colorectal cancer chemoprevention: is aspirin still in the game?
por: Grancher, Adrien, et al.
Publicado: (2022)

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
por: Ornelas, Argentina, et al.
Publicado: (2017)

Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)

Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)

Hormonal control of p53 and chemoprevention
por: Jerry, D Joseph, et al.
Publicado: (2002)

Chemoprevention for the Populations of Malaria Endemic Africa
por: Greenwood, Brian, et al.
Publicado: (2022)

Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota
por: Diao, Feiyu, et al.
Publicado: (2020)

Chemoprevention by aspirin against inflammation-related colorectal cancer in mice
por: Ohnishi, Shiho, et al.
Publicado: (2021)

Uncovering the mechanisms underlying the social patterning of diabetes
por: Lynch, Elizabeth B.
Publicado: (2020)

Prophylactic Aspirin and Public
por: Morgan, Gareth
Publicado: (2013)

Aspirin in tuberculous meningitis
por: Davis, Angharad G, et al.
Publicado: (2021)

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
por: Goh, Myung Ji, et al.
Publicado: (2022)

Obesity and psychotic disorders: uncovering common mechanisms through metabolomics
por: Orešič, Matej
Publicado: (2012)

Changing TACTICS in intermediate HCC: TACE plus sorafenib
por: Radu, Pompilia, et al.
Publicado: (2020)

Tight Junction Proteins and the Biology of Hepatobiliary Disease
por: Roehlen, Natascha, et al.
Publicado: (2020)

Uncovering Potential Mechanisms of the Relationship Between Structural Deficits and General Psychopathology
por: Kaczkurkin, Antonia N.
Publicado: (2022)

Aspirin and immunotherapy: a Faustian bargain?
por: Goethe, Eric A., et al.
Publicado: (2023)

Tracing lineages to uncover neuronal identity
por: Panman, Lia, et al.
Publicado: (2011)

Combining malaria vaccination with chemoprevention: a promising new approach to malaria control
por: Greenwood, Brian, et al.
Publicado: (2021)

Association of Long-term Use of Low-Dose Aspirin as Chemoprevention With Risk of Lung Cancer
por: Ye, Shinhee, et al.
Publicado: (2019)

Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Evaluation of the chemopreventive potentials of ezetimibe and aspirin in a novel mouse model of gallbladder preneoplasia
por: Rosa, Lorena, et al.
Publicado: (2020)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Pro-oxidant activity of dietary chemopreventive agents: an under-appreciated anti-cancer property
por: Azmi, Asfar S, et al.
Publicado: (2013)

Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications
por: Cadavid, Angela P.
Publicado: (2017)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
por: Algra, Ale, et al.
Publicado: (2000)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer
por: Rigas, B, et al.
Publicado: (2008)

Intra-platelet Serotonin as a Biomarker in HCC Recurrence: When Time Matters
por: Aryal, Bibek, et al.
Publicado: (2019)

Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials
por: Kraglund, Frederik, et al.
Publicado: (2023)

Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice
por: Lance, Peter, et al.
Publicado: (2011)

Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs
por: Kangaslampi, Samuli
Publicado: (2020)

Arresting the Culprit: Targeted Antagomir Delivery to Sequester Oncogenic miR-221 in HCC
por: Kasinski, Andrea L, et al.
Publicado: (2012)

Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development
por: Virzì, Alessia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qo4t1qiql7ji8qv305bh07g85r